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Introduction
A role for microorganisms in the development of
inﬂammatory arthropathies has long been recognized.
Since the description of reactive arthritis, bacteria
have been linked to bouts of arthritis that are thought
to occur in a genetically susceptible host, after
triggering by an infectious organism.
In a recent article, Toivanen (2003) has proposed
that arthritis results from bacteria encountered in the
intestinal microbiota. Apparently, processed products
of these bacteria gain access to the circulation and are
entrapped in the joints, where immunocompetent
cells, after being primed by these bacterial products,
initiate and may then perpetuate an inﬂammatory
response. Data to support this hypothesis are explored
in that paper, as follows: arthritogenic bacteria usually
are encountered in the gut. In addition, bacterial
products were shown to promote synovitis experimen-
tally and eradication of some infections may amelio-
rate or even abrogate the development of chronic
synovitis. This microbiota hypothesis may also apply
to certain viruses. The genetic component that is
believed to be relevant in the pathogenesis of chronic
arthritis is also contemplated in that “microbiota
theory”. Indeed, differences in the intestinal ﬂorawere
reported in patients with rheumatoid arthritis, as
compared to healthy individuals. Also, genetic
variations may account for differences in the intestinal
microbiota. Other examples trying to substantiate
this hypothesis are appearing in the literature. In a
very recent paper, antibacterial peptide antibodies
were proposed to be used as indices to support the
diagnosis of rheumatoid arthritis and ankylosing
spondylitis (Rashid et al. 2006).
Though we consider this hypothesis very exciting,
we will try to explore a somewhat opposite view. The
contribution of genetics to the pathogenesis of
inﬂammatory arthropathies cannot be overempha-
sized. However, to date, despite all the efforts made,
the closer and most relevant association of a genetic
component for arthritis refers to the human histo-
compatibility antigen HLA-B27 and the inﬂammatory
spondyloarthropathies (Khan and Ball 2002). How-
ever, that association does not apply worldwide, as it is
in white Caucasians. Actually, there are reports that
some HLA-B27 variants, deﬁned by the most recent
molecular biology techniques, may even confer
protection for the development of spondylitis (Khan
and Ball 2002).
The reduced coincidental prevalence of auto-
immune disease among identical twins does also
argue against a prominent genetic component in the
pathogenesis of these entities. In rheumatoid arthritis,
the concordance rate for twins varies from 15 to 30%
(MacGregor et al. 2000). This does also apply for
other autoimmune disorders such as insulin-depen-
dent diabetes mellitus, where the concordance rate is
around 40% (Hyttinen et al. 2003).
The prevalence of rheumatoid arthritis is very
similar worldwide. However, numbers appear to be a
bit higher in developed countries, with a prevalence of
0.5–1.0%, whereas in underdeveloped countries this
prevalence ranges from 0.1 to 0.5% (Alamanos and
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ducted epidemiological studies in the later compro-
mise a more strict appreciation of these numbers.
From Sa ˜o Paulo to Fortaleza
Socioeconomic disparities should inﬂuence the preva-
lence and the clinical picture of diseases worldwide.
Recent data have emphasized that delay in diagnosis,
difﬁculties in the access to a specialist, poor
compliance to treatment and failure and delay in the
indication of disease-modifying compounds have a
profound impact in the evolution of autoimmune
diseases. This appears to be particularly true for
systemic lupus erythematosus and rheumatoid
arthritis.
We work in the northeast of Brazil, in the state of
Ceara ´. The city—Fortaleza—is located around 48S
latitude, by the Atlantic coast with around 2,500,000
inhabitants including the metropolitan area. Tem-
peratures are stable around the year, varying from 22
to 328C, and there is a low rainfall index. It is one of
the poorest areas of the country, with a mean annual
income rate of less than 2000 US$ per capita (IBGE-
Brasil 2000). The health system in Fortaleza is a
reference for the whole state of Ceara ´. This means that
around 7,000,000 people, the population of the state,
seek specialized medical care in Fortaleza.
After completing postgraduation in Sa ˜o Paulo, that
is located 3000km south from Fortaleza, and a
postdoctoral fellowship in Sherbrooke-Que ´bec, we
moved back to Fortaleza to teach and practice
rheumatology. During the ﬁrst 3 years of rheumatol-
ogy practice, I realized that many patients with
inﬂammatory axial disease could be best classiﬁed as
having undifferentiated spondyloarthropathies. This
is to say that despite presenting axial and peripheral
inﬂammatory pain, the vast majority of the patients
had normal X-rays, even after 20 years of symptoma-
tology. In addition, the patients with rheumatoid
arthritis did not seem to be more severe as compared
to my experience in Sa ˜o Paulo. This was very
intriguing to me, if we consider that Sa ˜o Paulo is a
developed state. My belief was that better education
and higher lifestyle should positively inﬂuence the
outcome of these disorders.
We have just started an epidemiologic survey in
order to quantitatively assess our experience. How-
ever, data from the literature support our impression
that these people, with a low socioeconomic status,
poor access to the health system as well to
medications, do not behave worse with regard to
severity of inﬂammatory arthropathies, as might be
anticipated. A recent publication from our region
showedthatpeoplewith systemiclupuserythematosus
intheneighbor stateofRioGrandedoNortedisplayed
similar damage, measured by the SLICC criteria, as
compared to series reported from developed countries
(Vilar et al. 2005). Except for more severe skin lesions,
the clinical picture of these chronic patients was very
similar to the casuistic reported in developed
countries. We should stress that the high index of
insolation as well as inadequate use of sun protectors
should probably be the reason for this increased
damage to the skin.
What could possibly bedifferent inourenvironment
thatprotectedour patientsfromtheexpected crippling
destiny of rheumatoid arthritis? We will try to present
data that the answer may be “ﬂoating in the gut.”
In the gut
The Brazilian northeast is a highly endemic region of
helminthiasis. Actually, our numbers of parasitic
infestations are not known. However, the prevalence
is so high that we usually treat patients, especially
children, with symptoms that could be attributed to
helminthiasis, without relying on stool examination.
Investigation of inﬂammatory bowel diseases usually
waits for the result of anti-helminthics and anti-
protozoan medications in our daily practice. Chronic
phases of schistosomiasis still occur, sometimes with
the full-blown picture of hepatosplenomegaly.
Data from the literature have long supported a role
for helminths in the modulation of inﬂammation. This
subject has been elegantly explored in a recent review
(Dunne and Cooke 2005). Particularly, schistosoma
worms or its components were shown to ameliorate
experimentally induced diseases as the experimental
allergic encephalomyelitis, diabetes, and thyroiditis.
Trypanosoma brucei wasshowntoinhibitthedevelopment
of collagen-induced arthritis (Reviewed by Dunne and
Cooke 2005). Perhaps more signiﬁcant, inﬂammatory
bowel disease in humans, that share some pathogenetic
mechanism with inﬂammatory arthropathies, has been
successfully treated by the oral administration of
Thichuris suis eggs (Summers et al. 2005).
Considering the above, our hypothesis is that the
similar or even lower (still to be proven) disease
severity of the autoimmune rheumatic diseases in the
northeast of Brazil is at least partially linked to
endemic worm’s infestations.
Previous studies from a group that we collaborate
with have shown anti-inﬂammatory properties of an
extract obtained from Ascaris suum (Soares et al.
1992). They have looked to immunoglobulin pro-
duction, showinga decrease in both IgGand IgE levels
after the administration of the A. suum extract to mice
and rats. More recently, they are working on the
modulation of experimental asthma, exploring the
properties of A. suum components in the modulation
of allergic inﬂammation (Itami et al. 2005).
Zymosan-induced arthritis
The zymosan-induced arthritis model is character-
ized, in its acute phase, by a pronounced cellular
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neutrophils. After 24h, the cell inﬂux subsides and
there is a switch where mononuclear cells become
predominant. After a single joint injection of 1mg
zymosan, the arthritis progresses and, in the chronic
phase, between 7 and 14 days, severe destruction of
the cartilage appears (Rocha et al. 1999). We have
been working in this model in the past 15 years. Using
the test for articular incapacitation for rats, we
standardized the acute joint hyperalgesia that happens
in the zymosan arthritis (Rocha et al. 1999). Further,
wealso developed a method to directly quantitate joint
damage, by measuring the glycosaminoglycan content
of the articular cartilage (Bezerra et al. 2004).
Therefore, we are currently using the zymosan
arthritis model as a means of studying inﬂammatory
phenomena coupled to functional (pain) and struc-
tural damage parameters.
Ascaris suum and experimental arthritis
During the II Latin–American Congress of Auto-
immunity, held in Rio de Janeiro, Brazil, in April
2006, we presented preliminary data obtained from
our group, where we evaluated the effect of the
administration of an extract obtained from adult
A. suum worms in the zymosan-induced arthritis
model.
Our data revealed that parenteral, as well as oral
administration of the A. suum extract to rats subjected
to zymosan arthritis produced a dose-dependent
signiﬁcant reduction of the acute cell inﬁltration into
the joint cavities. Additionally, joint hyperalgesia was
also signiﬁcantly inhibited, as compared to vehicle-
treated rats. Similar data were obtained in mice
subjected to zymosan-arthritis. Moreover, the chronic
synovitis, evaluated by histopathology, was clearly
abrogated, with a scant presence of lymphocytes and
macrophages in the synovia of the animals that
received the A. suum extract prior to the intra-
articular injection of the zymosan. Finally, assessment
of articular cartilage damage, by measurement of its
glycosaminoglycan content, revealed that in the rats
subjected to zymosan arthritis that received the A.
suum extract there was a prevention of the glycosa-
minoglycan loss, as compared to vehicle-treated
animals. In an attempt to explore the mechanisms
involved in this protective effect, we obtained that the
levels of interleukin-1b, but not those of tumor
necrosis factor-a, measured in the joint cavities, were
signiﬁcantly reduced in the group of animals that
received the A. suum extract, as compared to vehicle-
treated animals.
In summary, our data provide evidence that a
helminth extract provides anti-inﬂammatory effects in
an experimental arthritis model. The fact that the
extract was equally effective regardless of being
injected parenterally or orally suggests that it has
pathophysiological relevance. Further, the phenom-
enon is not species-dependent, as it appeared in rats
and mice and is associated to alteration in the local
release of cytokines, in the joint milieu. We should also
stress that the beneﬁt occurred both at a functional
and structural level, since the joint hyperalgesia, as
well as the articular cartilage damage, were signiﬁ-
cantly reduced.
Concluding remarks
Considering these data, coupled to the epidemiolo-
gical aspects mentioned above, we sustain our
proposal that the clinical picture of autoimmune
diseases, at least the autoimmune rheumatic diseases,
in humans, is probably affected by the exposure of
these patients to helminths. The present data were
obtained with a nematode, i.e. A. suum, but we would
not be surprised if other parasites, as well as protozoa,
may probably affect the evolution of autoimmune
diseases. The implications of these data to our
understanding of the immunoinﬂammatory regu-
lation of autoimmune diseases can be clearly
visualized. However, we also anticipate that thera-
peutic strategies may be generated from the better
understanding of these pathways.
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